The photophysical properties of a series of prepared ruthenium tris(bipyridine) complexes, covalently linked to aromatic species, of type [Ru(bpy)(2)-(4-methyl-4'-(arylaminocarbonyl)-2,2'-bipyridine)](2+) ([Ru(bpy)(2)(mbpy-L)](2+), where bpy = 2,2'-bipyridine; mbpy = 4-methyl-4'-carbonyl-2,2'-bipyridine; and L = 2-aminonaphthyl (naph), 9-aminoanthryl (anth), 1-aminopyrenyl (pyr), or 9-aminoacridinyl (acrd)) were studied by electronic absorption spectroscopy and steady state and time resolved luminescence spectroscopies. The absorption spectra of the MLCT electronic transition of the complexes are similar, which is in agreement with a practically constant redox potential of Ru(III/II) close to 1.28 V versus Ag/AgCl. However, the luminescence spectra of the new complexes are red shifted compared to Ru(bpy)(3)(2+), and this effect is ascribed to solvation and inductive effects of the amide group which enhance the symmetry breakdown among the three bipyridyl ligands. The energy stabilization of the (3)MLCT state is in the range 2.1-8.4 kJ/mol. The triplet-triplet energy transfer between the Ru complex and the aromatic species linked by an amide spacer is a slow process with rate constants of 2.6 x 10(4), 3.6 x 10(4), and 4.9 x 10(4) s(-)(1) for anthracene, acridine, and pyrene as acceptors in methanol, respectively. The energy transfer rate constant increases with decreasing polarity of the solvent. In dichloromethane, the rate constants for anthracene, acridine, and pyrene acceptors are 2.6 x 10(5), 1.5 x 10(5), and 2.9 x 10(5) s(-)(1), respectively. The low efficiency of energy transfer is due to the small difference in triplet energy between donor and acceptor species, weak electronic coupling, and unfavorable Franck-Condon factors, despite the short separation distance between donor and acceptor species in an amide bridge.

Ruthenium polypyridine complexes have shown promise as agents for photodynamic therapy (PDT) and tools for molecular biology (chromophore-assisted light inactivation). To accomplish these tasks, it is important to have at least target selectivity and great reactive oxygen species (ROS) photogeneration: two properties that are not easily found in the same molecule. To prepare such new agents, we synthesized two new ruthenium complexes that combine an efficient DNA binding moiety (dppz ligand) together with naphthyl-modified (1) and anthracenyl-modified (2) bipyridine as a strong ROS generator bound to a ruthenium complex. The compounds were fully characterized and their photophysical and photochemical properties investigated. Compound 2 showed one of the highest quantum yields for singlet oxygen production ever reported (Φ= 0.96), along with very high DNA binding (log K = 6.78). Such photochemical behavior could be ascribed to the lower triplet state involving the anthracenyl-modified bipyridine, which is associated with easier oxygen quenching. In addition, the compounds exhibited moderate selectivity toward G-quadruplex DNA and binding to the minor groove of DNA, most likely driven by the pendant ligands. Interestingly, they also showed DNA photocleavage activity even upon exposure to a yellow light-emitting diode (LED). Regarding their biological activity, the compounds exhibited an exciting antibacterial action, particularly against Gram-positive bacteria, which was enhanced upon blue LED irradiation. Altogether, these results showed that our strategy succeeded in producing light-triggered DNA binding agents with pharmacological and biotechnological potential.

Aiming at the development of novel NO donors, the synthesis and reactivity of the trans- [Ru(bpy)

No abstract